DS
ANAC

DRW Securities’s ANACOR PHARMACEUTICALS INC COM ANAC Stock Holding History

DRW Securities’s Portfolio ANAC Stock Details ANAC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q1 		– Sell
-14,400
Closed -$464K – 170
2014
Q4 		$464K Buy
+14,400
New +$432K 0.05% 75

Other funds holding ANAC

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
EAM
Eagle Asset Management St Petersburg, Florida $19.6B AUM 41.58% 1-Year Est. Return
VM
VHCP Management New York $93M AUM 10.04% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
RCP
Rho Capital Partners New York $20.4M AUM

DRW Securities's ANAC Position: Q1 2015 in Review

DRW Securities sold out of ANACOR PHARMACEUTICALS INC COM (ANAC) in Q1 2015, closing a stake of 14,400 shares — an estimated $464K sold.

DRW Securities first reported a position in ANAC in Q4 2014 and held it in 1 quarter. The position peaked at $464K in Q4 2014. 157 funds tracked by Wall St. Rank hold ANAC as of Q1 2015.

  • DRW Securities reported no remaining ANACOR PHARMACEUTICALS INC COM position as of Q1 2015 after selling out during the quarter.
  • DRW Securities sold 14,400 ANACOR PHARMACEUTICALS INC COM shares in Q1 2015, an estimated $464K.
  • DRW Securities first reported a position in ANACOR PHARMACEUTICALS INC COM in Q4 2014 and held it in 1 quarter.
  • DRW Securities's ANACOR PHARMACEUTICALS INC COM position peaked at $464K in Q4 2014.
  • 157 funds tracked by Wall St. Rank held ANACOR PHARMACEUTICALS INC COM as of Q1 2015.

Based on DRW Securities's 13F filing for Q1 2015, filed 15 May 2015.